These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 1214504)

  • 21. [The role of intestinal microflora in the development of complications of hepatic cirrhosis-associated portal hypertension].
    Garbuzenko DV
    Klin Med (Mosk); 2007; 85(8):15-9. PubMed ID: 17926483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum laminin P1 levels do not reflect critically elevated portal pressure in patients with liver cirrhosis.
    Bahr MJ; Böker KH; Horn W; Günzler V; Manns MP
    Hepatogastroenterology; 1997; 44(16):1200-5. PubMed ID: 9261625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Medical therapy of portal hypertension due to liver cirrhosis].
    Cerini R; Sperandeo M; Varriale A; De Rosa ML; Cacciatore L
    Recenti Prog Med; 1991 Feb; 82(2):91-9. PubMed ID: 2034876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Portal hypertension in the absence of liver cirrhosis and extrahepatic circulatory blockade].
    Bykov VS
    Klin Med (Mosk); 1981 Oct; 59(10):22-6. PubMed ID: 7031355
    [No Abstract]   [Full Text] [Related]  

  • 25. Nicardipine infusion improved hepatic function but failed to reduce hepatic venous pressure gradient in patients with cirrhosis.
    Iwao T; Toyonaga A; Ikegami M; Sugawara H; Sumino M; Takagi K; Oho K; Sakaki M; Ohkubo K; Inoue R
    Am J Gastroenterol; 1992 Mar; 87(3):326-31. PubMed ID: 1539567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the short-term effects of mepindolol and propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis.
    Braillon A; Calès P; Lebrec D
    Int J Clin Pharmacol Res; 1985; 5(4):223-8. PubMed ID: 4055165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodynamics in the isolated cirrhotic liver.
    Zipprich A
    J Clin Gastroenterol; 2007; 41 Suppl 3():S254-8. PubMed ID: 17975473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Arterial blood supply of the liver in portal hypertension and liver cirrhosis].
    Voegeli E
    Schweiz Med Wochenschr; 1971 May; 101(20):767. PubMed ID: 5578420
    [No Abstract]   [Full Text] [Related]  

  • 29. Extraction of 125I-albumin microaggregates from portal blood. An index of functional portal blood supply in cirrhotics.
    Huet PM; Marleau D; Lavoie P; Viallet A
    Gastroenterology; 1976 Jan; 70(1):74-81. PubMed ID: 1245287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of intrahepatic pressure as an index of hepatic sinusoidal pressure.
    Saito M; Ohnishi K; Terabayashi H; Tanaka H; Iida S; Nomura F
    Am J Gastroenterol; 1987 Oct; 82(10):1057-61. PubMed ID: 3661515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrasting patterns of ascites formation in hepatic cirrhosis.
    Witte MH; Witte CL; Cole WR; Koehler PR
    JAMA; 1969 Jun; 208(9):1661-6. PubMed ID: 5818681
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacological treatment of portal hypertension.
    González-Abraldes J; Bosch J; García-Pagán JC
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1407-13. PubMed ID: 11890356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis.
    Pinzani M; Gentilini P
    Semin Liver Dis; 1999; 19(4):397-410. PubMed ID: 10643625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Implications of the arterialization of the sinusoid in its capillarization and in the maintenance of portal hypertension in the cirrhotic patient].
    Ceña Lázaro G; Barrao Comps F; Omiste Martínez JL; Ducóns García J; Rojo Puente S; Laquidaín Hergueta M; Bueno Gómez J
    Rev Esp Enferm Apar Dig; 1987 Feb; 71(2):111-3. PubMed ID: 3563042
    [No Abstract]   [Full Text] [Related]  

  • 35. [Echographic and hemodynamic indicators in liver cirrhosis with portal hypertension].
    Rikhsieva LE; Akhmedzhanova ShSh; Miasnik BN
    Sov Med; 1989; (2):13-5. PubMed ID: 2658117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver lymph: a critical component of hepatic cirrhosis.
    Dumont AE
    Major Probl Clin Surg; 1964; 1():176-88. PubMed ID: 4949991
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of somatostatin on splanchnic hemodynamics in liver cirrhosis].
    Merkel C; Gatta A; Zuin R; Finucci GF; Arnaboldi L; Ruol A
    Minerva Med; 1984 Nov; 75(44):2673-8. PubMed ID: 6151151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic venous pressure gradient and outcomes in cirrhosis.
    Ripoll C
    J Clin Gastroenterol; 2007; 41 Suppl 3():S330-5. PubMed ID: 17975485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of a nonselective beta-blocker, nadolol, in the treatment of portal hypertension in cirrhotics.
    Gatta A; Sacerdoti D; Merkel C; Rossoni R; Finucci G; Bolognesi M; Zuin R
    Int J Clin Pharmacol Res; 1985; 5(6):413-8. PubMed ID: 4093219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of mechanical factors on ascites formation in hepatic cirrhosis.
    Witte MH; Witte CL
    Lymphology; 1969 Sep; 2(3):89-91. PubMed ID: 5357967
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.